{"id":"W4400213250","doi":"10.4081/cardio.2024.40","title":"Baseline echocardiographic characteristics of patients enrolled in the randomized investigation of MitraClip device in heart failure (RESHAPE HF-2) trial: comparison with COAPT and Mitra-FR","year":2024,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Surgical Specialties (Canada); Health Care Foundation","funders":"Abbott Vascular; St. Jude Medical; Daiichi Sankyo Europe; Servier; Innosuisse - Schweizerische Agentur für Innovationsförderung; Vifor Pharma; Universität Zürich; CytoSorbents Europe; Deutsche Forschungsgemeinschaft; British Heart Foundation; Sanofi; Abiomed; Horizon Therapeutics; Pfizer; Moderna; MicroPort; Impulse Dynamics; Hamilton Health Sciences; Mundipharma Medical Company, Basel; Kiniksa Pharmaceuticals; Cytokinetics; Biosense Webster; Novo Nordisk; HeartWare; ZOLL Medical Corporation; Regeneron Pharmaceuticals; Boston Scientific Corporation; AstraZeneca; Amarin Corporation; Javna Agencija za Raziskovalno Dejavnost RS; Alexion Pharmaceuticals; Thoratec Corporation; Cardinal Health; Edwards Lifesciences; Amgen; Eli Lilly and Company; Bayer Vital; Bristol-Myers Squibb","keywords":"Medicine; Ejection fraction; MitraClip; Internal medicine; Cardiology; Heart failure; Randomized controlled trial; Mitral regurgitation","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002054233,0.0007465076,0.001685649,0.0002732393,0.0002982609,0.0006946728,0.000440521,0.001323464,0.003291626],"category_scores_gemma":[0.002127213,0.0003624748,0.001080267,0.0002754818,0.0004730868,0.0007660332,0.0003352111,0.001052304,0.0003603392],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002699791,"about_ca_system_score_gemma":0.0004295193,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003225983,"about_ca_topic_score_gemma":0.0005612067,"domain_scores_codex":[0.9989454,0.0004960889,0.00009885866,0.0002281594,0.00009322806,0.0001382922],"domain_scores_gemma":[0.9987831,0.000364666,0.0003019701,0.00009853501,0.00006589588,0.0003859944],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8994325,0.005946073,0.07714757,0.000389024,0.001935335,0.0001030016,0.00007297119,0.0004961056,0.002707246,0.0001563338,0.001021244,0.01059266],"study_design_scores_gemma":[0.4834775,0.1954781,0.310898,0.0001470795,0.003902905,0.0002708345,0.000161433,0.002143815,0.001172335,0.0004152884,0.001853836,0.00007893264],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963167,0.001610517,0.0001139912,0.0001525435,0.00006644568,0.0003364398,0.0006163683,0.000006571632,0.0007805548],"genre_scores_gemma":[0.9963761,0.0003846207,0.0001768435,0.0003270183,0.0001909812,0.0006083053,0.001425173,0.000003333107,0.0005075567],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003291626,"threshold_uncertainty_score":0.0110116,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01189000808189308,"score_gpt":0.3060940833949922,"score_spread":0.2942040753130991,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}